A detailed history of Atlantic Edge Private Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Atlantic Edge Private Wealth Management, LLC holds 130 shares of MRNA stock, worth $7,113. This represents 0.01% of its overall portfolio holdings.

Number of Shares
130
Previous 130 -0.0%
Holding current value
$7,113
Previous $13.9 Million 11.44%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$85.37 - $115.44 $42,685 - $57,720
-500 Reduced 79.37%
130 $13.9 Million
Q4 2023

Feb 08, 2024

BUY
$69.51 - $104.43 $43,791 - $65,790
630 New
630 $62.7 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Atlantic Edge Private Wealth Management, LLC Portfolio

Follow Atlantic Edge Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Edge Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Edge Private Wealth Management, LLC with notifications on news.